- Report
- October 2023
Japan
From €1430EUR$1,500USD£1,226GBP
- Report
- October 2023
Italy
From €1430EUR$1,500USD£1,226GBP
- Report
- October 2023
Germany
From €1430EUR$1,500USD£1,226GBP
- Report
- October 2023
France
From €1430EUR$1,500USD£1,226GBP
- Report
- December 2022
France
From €1430EUR$1,500USD£1,226GBP
- Report
- March 2024
- 132 Pages
Global
From €906EUR$950USD£776GBP
- Report
- August 2022
- 329 Pages
Global
From €3518EUR$3,690USD£3,016GBP
Immunofluorescence is a technique used in In Vitro Diagnostics (IVD) to detect the presence of antigens in a sample. It is based on the principle of fluorescent labeling, where a fluorescent dye is used to bind to a specific antigen. The antigen-dye complex is then detected using a fluorescence microscope. Immunofluorescence is used in a variety of IVD applications, including the diagnosis of infectious diseases, autoimmune diseases, and cancer. It is also used to detect the presence of antibodies in a sample, which can be used to diagnose allergies and autoimmune diseases.
The Immunofluorescence market is a rapidly growing segment of the IVD market, driven by the increasing demand for accurate and reliable diagnostic tests. The market is expected to benefit from the development of new technologies, such as multiplexing, which allow for the simultaneous detection of multiple antigens in a single sample.
Some companies in the Immunofluorescence market include Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, Agilent Technologies, and PerkinElmer. Show Less Read more